Funded Tech Companies
Grit Biotechnology
Wondering who provided funding to Grit Biotechnology? Matrix Partners, Qianhai Ark and HeFangTian Venture Partnership invested in this biopharmaceutical company.
Company Overview
Company Name
Grit Biotechnology
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Room 110-431, Building 18, Creative Valley, No. 1889 Huandao
Zhuhai, Guangdon, Undisclosed
CN
Zhuhai, Guangdon, Undisclosed
CN
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Grit Bio is a Chinese cell therapy company founded in 2019. The company is developing tumor-infiltrating lymphocyte (TIL) therapy program to address the unmet medical needs and to improve the quality of life for patients with solid tumor. GT101 - Grit's non-gene-modified TIL product manufactured using proprietary process - is the first TIL product received Investigational New Drug (IND) approval in China and is currently in Phase 1 clinical trial.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/8/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yarong Liu
Company Investors
- Matrix Partners
- Qianhai Ark
- HeFangTian Venture Partnership
- CICC Capital
- Liando Investment
- Yuanhe Capital
- Sherpa Healthcare Partners
- Decheng Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs